We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Delivering Portable Chest Radiography Through Glass (TG-CXR) Reduces COVID-19 Infection Risk in Hospitals

By HospiMedica International staff writers
Posted on 20 Apr 2021
Illustration
Illustration
A study to understand the cost and benefit of adopting portable chest radiography through glass (TG-CXR) at a tertiary care centre during the COVID-19 pandemic has found the novel technique to be particularly beneficial.

A team of two technologists at the Department of Radiology, St. Michael's Hospital, University of Toronto (Toronto, ON, Canada) were trained on the TG-CXR method which has the benefit of allowing one technologist to stay outside of the patient room while operating the portable radiography machine, thus reducing PPE use, decreasing the frequency of radiography machine sanitization and reducing their exposure to potentially infectious patients.

The cost of implementing the technique during the current COVID-19 pandemic was obtained from the department's operational database. The direct cost of routinely used PPE and sanitization materials and the cost of the time taken by the technologists to clean the machine was used to form a quantitative picture of the benefit associated with TG-CXR technique.

The technologists were trained on the TG-CXR method during a 15 minute shift change briefing. This translated to a one-time cost of USD 424.88. There was an average reduction of portable radiography machine downtime of four minutes and 48 seconds per study. The benefit of adopting the TG-CXR technique was USD 9.87 per patient imaged, resulting in a projected net cost savings of USD 51,451.84 per annum. Thus, the study concluded that adoption of the TG-CXR technique during the COVID-19 pandemic involves a minimal one-time cost, but can result in a significant benefit over the year.

"We hope that our findings would encourage policy-makers to implement TG-CXR technique at their institutions when and where possible," the study concluded.

Related Links:
University of Toronto

Gold Member
12-Channel ECG
CM1200B
Gold Member
Blood Gas Analyzer
i-Check200
Medical Adhesive
MED 5570U
Medical-Grade Display
HL2316SHTB

Channels

Critical Care

view channel
Image: The proposed sensor incorporates two ion-selective electrodes and a liquid-junction reference electrode, which allows the device to operate without the need for long pre-adjustment periods. (Photo courtesy of Associate Professor Isao Shitanda from Tokyo University of Science, Japan)

Wristwatch Sensor Tracks Sodium and Potassium in Sweat in Real Time

Sweat can provide real-time biochemical information about the body’s physiological state, with sodium and potassium measurements offering potential value for monitoring people working or exercising in... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more